Pacer Advisors Inc. Acquires 1,620 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pacer Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 46,034 shares of the medical equipment provider’s stock after purchasing an additional 1,620 shares during the quarter. Pacer Advisors Inc.’s holdings in Intuitive Surgical were worth $24,028,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the third quarter valued at $558,807,000. International Assets Investment Management LLC increased its position in Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares in the last quarter. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB boosted its holdings in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, State Street Corp increased its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,265 shares of company stock valued at $21,964,281 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Down 1.8 %

NASDAQ ISRG opened at $573.48 on Tuesday. The firm has a market cap of $204.26 billion, a P/E ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The company’s 50 day moving average is $547.16 and its 200-day moving average is $505.21. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Analyst Ratings Changes

A number of research analysts have weighed in on ISRG shares. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday. They issued a “neutral” rating and a $550.00 price objective on the stock. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday. Finally, Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.